PATENT CLAIM ANALYSIS

Application Number: 15991710
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-12
Patent Classification: ["514", "025000"]

Abstract:
Provided herein are compounds of Formula (I) and uses thereof for inhibiting the activity of D-amino acid oxidase (DAAO) or treating diseases or disorders associated with DAAO, such as a central nervous system (CNS) disorder, obesity, diabetes, or hyperlipidemia. Also provided in the present disclosure are methods of synthesizing the Formula (I) compounds described herein.

Claim (Index 2):
The compound of  claim 1 , wherein Ring A is:

Metadata:
- Claim Count in Document: 33.0
- Percentile: 93.0
- Lexical Diversity: 1.46809
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13789967', '15303736', '13792105', '15858733', '15549152']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7184852115568175
- 35 USC 102 Novelty (BERT): 0.5157553641323661
- Combined Prediction Score: 0.6982122268143724
- Mean Citation Score: 214.937642
- Max Citation Score: 222.59274
- Similarity Product: 134.03015036568402

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test